News Main Page
Email A Friend
October 15, 2018
California’s Division of Workers’ Compensation Posts Proposed Revisions to WCIS Implementation Guide for First and Subsequent Reports of Injury
October 15, 2018
California’s Division of Workers’ Compensation Posts 2017 Audit Unit Annual Report and the Ranking Report
October 11, 2018
Sam Solakyan, Owner of Vital Imaging, Released From Federal Prison On 1.5 Million Dollars Bond
October 7, 2018
Judge Has Questions for Prosecution in Sim Hoffman, M.D. Case in Orange County. Still No Ruling on Defense’s 995 Motion.
|California’s Division of Workers’ Compensation Posts Proposed Amendments to Pharmaceutical Fee Schedule to Online Forum for Public Comment|
By Lonce Lamonte and the California Department of Industrial Relations' Newsline - September 27, 2018
The Division of Workers’ Compensation (DWC) has posted proposed amendments to the Pharmaceutical Fee Schedule to its online forum where members of the public may review and comment on the proposal.
Under the California Labor Code, the fee schedule for pharmaceuticals is based primarily upon the Medi-Cal pharmacy payment system. Medi-Cal is now implementing a revised payment methodology approved by the Centers for Medicare and Medicaid Services (CMS). Background information on the Medi-Cal changes can be reviewed on the Department of Health Care Services (DHCS) Pharmacy Reimbursement Project web page. Due to requirements of federal law, the DHCS will implement Medi-Cal pharmacy fee schedule changes retroactively to April 1, 2017. For workers’ compensation, fee schedule changes will not be retroactive; the draft regulations propose that the new methodology become effective for pharmaceuticals dispensed on or after January 1, 2019.
The following regulation changes are proposed to implement Labor Code section 5307.1 and to align the fee schedule with the new Medi-Cal system:
Elimination of the Average Wholesale Price (AWP) minus 17 percent as a benchmark for the drug ingredient;
Revised methodology for payment of the drug ingredient, which sets the maximum at the lower of the following:
National Drug Acquisition Cost (NADAC) or Wholesale Acquisition Cost (WAC) for drugs lacking a NADAC price;
Federal Upper Limit;
Maximum Allowable Ingredient Cost (MAIC);
Usual and Customary Charge;
Adoption of the revised two-tier Medi-Cal dispensing fee structure for pharmacies (which increases the dispensing fee from the current $7.25 to $10.05, or to $13.20 for those pharmacies listed by Medi-Cal as eligible for the higher fee);
Rules addressing fees for compounded drugs and repackaged drugs.
The forum can be found on the DWC forums web page under “current forums.” Comments will be accepted on the forum until Monday, October 8.
# # #
firstname.lastname@example.org, Lonce Lamonte, journalist, in conjunction with the California Department of Industrial Relations' Newsline.